Application Nr Approved Date Route Status External Links
NDA021747 None Respiratory (inhalation) None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Combivent Respimat Is Indicated For Use In Patients With Chronic Obstructive Pulmonary Disease (copd) On A Regular Aerosol Bronchodilator Who Continue To Have Evidence Of Bronchospasm And Who Require A Second Bronchodilator. Combivent Respimat Inhalation Spray Is A Combination Of An Anticholinergic And Beta 2 ‑adrenergic Agonist Indicated For: Patients With Chronic Obstructive Pulmonary Disease (copd) On A Regular Aerosol Bronchodilator Who Continue To Have Evidence Of Bronchospasm And Who Require A Second Bronchodilator (1)

All Formulated Excipients (0 Total)

None

Active Ingredients ( 2 Total)

Comments